glp-1 gen 5 GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome Product information includes sequence Glucagon-like peptide 1 receptor agonists

L.KatonW.KroenkeK

Zepbound is part of the drug class called GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonists

Key Takeaways GLP-1 medication starts showing initial effects and early signs of appetite reduction and improved blood sugar control within the first few weeks

And getting it wrong can directly impact how well your medication works over time

LIVE TO 100 A focus on systems Medicine 2.0 treats diseases and risk factors as existing in a silo

Chronic inflammation is associated with conditions like heart disease, Alzheimers disease and cancer, according to the Cleveland Clinic